Berry GenomicsLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Yang Gao
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 9.0% |
| Management average tenure | no data |
| Board average tenure | 2.2yrs |
Recent management updates
Recent updates
Berry Genomics Co.,Ltd's (SZSE:000710) Shares Bounce 34% But Its Business Still Trails The Industry
Feb 10
Lacklustre Performance Is Driving Berry Genomics Co.,Ltd's (SZSE:000710) Low P/S
Dec 10Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth
May 21Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%
Mar 08CEO
Yang Gao (44 yo)
Dr. Yang Gao is Chairman at Berry Genomics Co., Ltd. and Director since July 20, 2017 and serves as its General Manager since September 30, 2021. He served as Acting Chief Financial Officer at Berry Genomi...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 7.8yrs | CN¥1.22m | 9.05% CN¥ 411.7m | |
| CFO, Deputy GM & Director | 1.8yrs | CN¥446.30k | no data | |
| Director | 7.8yrs | no data | no data | |
| Supervisor | 4.8yrs | no data | no data | |
| Independent Director | 1.8yrs | CN¥33.30k | no data | |
| Director | 1.8yrs | CN¥33.30k | no data | |
| Independent Director | 1.8yrs | CN¥33.30k | no data | |
| Independent Director | 2.6yrs | CN¥80.00k | no data | |
| Chairman of the Supervisory Board | 1.8yrs | no data | no data | |
| Employee Supervisor | 2.8yrs | no data | no data |
Experienced Board: 000710's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 09:46 |
| End of Day Share Price | 2025/05/22 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Berry Genomics Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue Gao | Changjiang Securities Co. LTD. |
| Hanqing Zhu | Guosen Securities Co., Ltd. |
| Yinglan Shu | Haitong International Research Limited |